USA - NASDAQ:RGC - KYG7487R1002 - Common Stock
The current stock price of RGC is 13 USD. In the past month the price decreased by -27.58%. In the past year, price increased by 7958.72%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 46.52 | 968.11B | ||
| JNJ | JOHNSON & JOHNSON | 18.81 | 470.23B | ||
| MRK | MERCK & CO. INC. | 10.55 | 232.12B | ||
| PFE | PFIZER INC | 8.06 | 146.63B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.41 | 98.98B | ||
| ZTS | ZOETIS INC | 19.11 | 53.70B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.67 | 23.17B | ||
| VTRS | VIATRIS INC | 4.68 | 12.72B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.91 | 10.92B | ||
| CORT | CORCEPT THERAPEUTICS INC | 86.08 | 7.98B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.86B | ||
| LGND | LIGAND PHARMACEUTICALS | 27.61 | 3.94B |
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
REGENCELL BIOSCIENCE HOLDING
11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
Hong Kong 37918 HK
CEO: Yat-Gai Au
Employees: 12
Phone: 85221550823
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
The current stock price of RGC is 13 USD. The price decreased by -4.97% in the last trading session.
RGC does not pay a dividend.
RGC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
RGC stock is listed on the Nasdaq exchange.
REGENCELL BIOSCIENCE HOLDING (RGC) currently has 12 employees.
ChartMill assigns a technical rating of 3 / 10 to RGC. When comparing the yearly performance of all stocks, RGC is one of the better performing stocks in the market, outperforming 99.97% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to RGC. While RGC has a great health rating, there are worries on its profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -54.68% | ||
| ROE | -60.86% | ||
| Debt/Equity | 0 |